Food and Drug Administration

Transmissible Spongiform Encephalopathies Advisory Committee

July 17, 2003

Briefing Information

Background Information for Safety of Bovine Bone Gelatin in Oral and Topical Drugs, Foods and Cosmetics, FDA (PDF)

Memorandum From the FDA Gelatin Planning Work Group to the Committee Regarding Safety of Bovine Bone Gelatin in Oral and Topical Drugs, Foods and Cosmetics (PDF)

Table of Contents (PDF)

The Removal and Inactivation of Potential TSE Infectivity by the Different Gelatin Manufacturing Processes, Prepared by the Gelatine Manufacturers of Europe (PDF)